Evidence map›Paper›PMID 33086625›Full record

ArticleCancers2020

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine.

Natsuko Kondo, Masaki Hikida, Mitsutoshi Nakada, Yoshinori Sakurai, Eishu Hirata, Satoshi Takeno, Minoru Suzuki

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Natsuko KondoInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Masaki HikidaDepartment of Life Science, Akita University, Akita 010-8502, Japan.
Mitsutoshi NakadaDepartment of Neurosurgery, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8640, Japan.ORCID 0000-0001-9419-6101
Yoshinori SakuraiInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Eishu HirataDivision of Tumor Cell Biology and Bioimaging, Cancer Research Institute of Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0001-7479-7460
Satoshi TakenoInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.ORCID 0000-0002-8761-3461
Minoru SuzukiInstitute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka 590-0494, Japan.
Kyoto University · JPKanazawa University · JPAkita University · JP

Funding

Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University 2019-2020Japan Society for the Promotion of Science KAKENHI JP 16673074Scientific Research by SGH Foundation 28
6 · The paper itself

Abstract

As glioma stem cells are chemo- and radio-resistant, they could be the origins of recurrent malignant glioma. Boron neutron capture therapy (BNCT) is a tumor-selective particle radiation therapy.

Indexed as

boron neutron capture therapyboronophenylalanineglioma stem cellmass cytometry

Identifiers

PMID33086625
PMCPMC7603373
OpenAlexW3093478149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.